Targeted Therapy Welfare Fund 2018
Breast cancer is the most common cancer in women worldwide. The management of breast cancer is complex in nature and is usually customized specifically for individual patients. 1 in 5 breast cancer patients are tested positive for Human Epidermal growth factor Receptor 2 (HER2). HER2 is a protein in the body that promotes the growth of cancer cells aggressively. For breast cancer patients who are HER2-positive (HER2+), doctors often prescribe a drug called Trastuzumab alongside other treatments such as surgery, chemotherapy & radiotherapy to enhance the outcome of the treatment. This treatment however is very costly and many patients could not afford to pay for it. As a result, many such patients risk poor treatment outcome and even recurrences.
The Targeted Therapy Welfare Fund for Breast Cancer is a corporate social responsibility (CSR) program initiated by Beacon Hospital and Roche Malaysia. The objective of this program is to reduce the financial burden of breast cancer patients by enabling them to gain access to targeted therapy (Trastuzumab). Under this program, deserving breast cancer patients are given access to this treatment at a subsidized rate. Patients only need to pay RM2500 per cycle for trastuzumab treatment.
To apply and enrol in this program, patients must first consult our oncologist as outpatient (consultation charges apply). The attending oncologist will then refer the case to Beacon’s CSR office for financial assessment and eligibility. It will take approximately 3 – 5 working days to process the application. Applicants are encouraged to provide supporting documents promptly to avoid delays. Once the application is approved, the patient will be provided with a guarantee letter which will enable the patient to get the treatment done at the agreed subsidised cost.
Targeted therapy medicine (Trastuzumab) * subcutaneous
Day-care charges / Drug preparation / Medical consumables
Nursing charges / Monitoring equipment
Doctor’s fee (RM150 per cycle only)
Lab tests (if needed)
Additional medication (if needed)
Hospitalisation / Critical care (if needed)
For more info, kindly contact our CSR department at 03 – 7620 7979 or 011 – 1090 6588